Sarepta Therapeutics Price Target Cut to $181.00/Share From $182.00 by RBC Capital
Sarepta Therapeutics Price Target Cut to $181.00/Share From $182.00 by RBC Capital
RBC Capital将Sarepta Therapeutics的目标价从182.00美元/股下调至181.00美元/股。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册